Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKesson
McKinsey
Boehringer Ingelheim
Baxter
Harvard Business School
Colorcon

Last Updated: January 21, 2022

DrugPatentWatch Database Preview

Investigational Drug Information for PF-04991532


Email this page to a colleague

« Back to Dashboard

What is the drug development status for PF-04991532?

PF-04991532 is an investigational drug.

There have been 9 clinical trials for PF-04991532. The most recent clinical trial was a Phase 2 trial, which was initiated on June 1st 2011.

The most common disease conditions in clinical trials are Diabetes Mellitus, Type 2, Diabetes Mellitus, and Glucose Metabolism Disorders. The leading clinical trial sponsors are Pfizer and [disabled in preview].

Recent Clinical Trials for PF-04991532
TitleSponsorPhase
A 2-week Trial Of PF-04991532 In Patients With Type 2 DiabetesPfizerPhase 1
Single Dose Study To Study The Absorption, Metabolism And Excretion Of PF-04991532PfizerPhase 1
Study To Evaluate The Effect Of Renal Impairment On The Pharmacokinetics Of PF-04991532PfizerPhase 1

See all PF-04991532 clinical trials

Clinical Trial Summary for PF-04991532

Top disease conditions for PF-04991532
Top clinical trial sponsors for PF-04991532

See all PF-04991532 clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
McKinsey
Boehringer Ingelheim
Baxter
Harvard Business School
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.